John Harold Leaman is Chief Fin. & Business Officer of Impel Pharmaceuticals Inc.
Person profile
Roles
Impel Pharmaceuticals
Chief Fin. & Business Officer
Address
San Francisco, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
144
IMPEL PHARMACEUTICALS INC
12 May 23
4
IMPEL PHARMACEUTICALS INC
16 Feb 23
4
IMPEL PHARMACEUTICALS INC
4 Jan 23
4
IMPEL NEUROPHARMA INC
28 Jan 22
4
IMPEL NEUROPHARMA INC
21 Oct 21
4
IMPEL NEUROPHARMA INC
26 Jul 21
3
IMPEL NEUROPHARMA INC
22 Apr 21
4
SELECTA BIOSCIENCES INC
19 Jun 18
4
SELECTA BIOSCIENCES INC
20 Nov 17
3
SELECTA BIOSCIENCES INC
26 Oct 17
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
14 Feb 23 | IMPL Impel Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 2.29 | 70,000 | 160.30 k | 70,000 |
31 Dec 22 | IMPL Impel Pharmaceuticals | Common Stock | Payment of exercise | Dispose F | No | No | 3.75 | 3,627 | 13.60 k | 6,944 |
31 Dec 22 | IMPL Impel Pharmaceuticals | Common Stock | Option exercise | Acquire M | No | No | 0 | 10,571 | 0.00 | 10,571 |
31 Dec 22 | IMPL Impel Pharmaceuticals | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 10,571 | 0.00 | 0 |